Suchergebnisse - "Dreger, Peter"

PubPharm (17)

1

Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG) : a multicentre, open-label, phase 2 trial

enthalten in: The Lancet. Haematology | 2022

von Cramer, P. | Fürstenau, M. | Robrecht, S. | +19

CommentIn: Lancet Haematol. 2022 Oct;9(10):e711-e712. - PMID 35988548

2

Is There a Role for Cellular Therapy in Chronic Lymphocytic Leukemia?

enthalten in: Cancer journal (Sudbury, Mass.) | 2021

von Dreger, P.

3

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L) : a randomised, non-inferiority, phase 3 trial

enthalten in: The Lancet. Haematology | 2020

von Beelen, D. | Trenschel, R. | Stelljes, M. | +56

4

Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T Cells

enthalten in: Frontiers in immunology | 2020

von Yang, M. | Wang, L. | Ni, M. | +15

5

Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients

enthalten in: International journal of cancer | 2019

von Stock, S. | Übelhart, R. | Schubert, M. | +19

6

Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysis

enthalten in: European journal of cancer (Oxford, England : 1990) | 2017

von Vidal, L. | Gafter-Gvili, A. | Salles, G. | +16

7

Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2016

von Kharfan-Dabaja, M. | Kumar, A. | Hamadani, M. | +25

8

Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial

enthalten in: British journal of haematology | 2015

von Witzens-Harig, M. | Benner, A. | McClanahan, F. | +12

9

Hope for high-risk chronic lymphocytic leukemia relapsing after allogeneic stem-cell transplantation

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Montserrat, E. | Dreger, P.

CommentOn: J Clin Oncol. 2015 May 10;33(14):1557-63. - PMID 25847930

10

Where does allogeneic stem cell transplantation fit in the treatment of chronic lymphocytic leukemia?

enthalten in: Current hematologic malignancy reports | 2015

von Dreger, P. | Montserrat, E. | European Society for Blood and Marrow Transplantation (EBMT) | +1